FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
The U.S. Food and Drug Administration on Friday approved a new ​formulation of Lantheus Holdings' prostate cancer imaging agent, aimed at improving ‌scanning access through increased production ...
Dr Fred Saad of the University of Montreal discusses the future direction of alpha emitter agents in the treatment of prostate cancer, emphasizing the logical progression of resea ...
In oligometastatic castration-resistant prostate cancer, the rationale to use local SBRT is improved disease control.
The therapy shrunk tumors in 46 percent of patients in a Phase I trial and showed strong PSA responses at the recommended dose.
Terrance Freeman shares his experience at the UF Health Proton Therapy Institute in this week’s Good News feature.
Proton therapy patient Keith Abbott recently sent a note to the care team at Fred Hutch – Proton Therapy. “In 2015 [10 years ago], I was diagnosed with stage 3 esophageal cancer,” he wrote. “After ...
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...
Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...
Add Yahoo as a preferred source to see more of our stories on Google. A different kind of radiation therapy can help cancer patients preserve who they are. About half of all cancer patients typically ...